Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multicenter, Open Label, Randomized Study of Two Titration Regimens of Oral CXA-10 in Subjects With Primary Focal Segmental Glomerulosclerosis (FSGS)

NCT03422510 is registered in ClinicalTrials.gov with Complexa, Inc. as lead sponsor.

NCT NCT03422510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03422510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multicenter, Open Label, Randomized Study of Two Titration Regimens of Oral CXA-10 in Subjects With Primary Focal Segmental Glomerulosclerosis (FSGS)
Lead sponsor
Complexa, Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 15, 2018
Completion date
July 31, 2020
Enrollment
33 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

primary focal segmental glomerulosclerosis